Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
This can help calm overactive immune responses attacking the thyroid gland, support tissue repair, and may reduce excessive levels of thyroid hormones
However, it is not recommended to combine it directly with high concentrations of vitamin C (L-ascorbic acid) or AHAs, as the acidic pH of these actives can destabilize the copper complex and reduce GHK-Cu efficacy
For more detailed information about lifestyle impacts on health, you might find this article on lifestyle choices insightful
